Esketamine & SPRAVATO® vs. IV Ketamine: Your Friendly 2026 Guide for Anxiety & Depression
Zora Neuro Spa Editorial · June 5, 2026

If you're exploring advanced treatments for depression or anxiety, you've likely come across both IV ketamine and Spravato® in your search for the best ketamine clinics in 2026. It can be confusing trying to figure out which is which, let alone which might be right for you. This guide is here to walk you through the key differences in a clear, friendly way, helping you understand the options available right here in the Boise area so you can have a more informed conversation with your doctor.
Quick Answer
IV ketamine and Spravato® (esketamine) are both powerful, rapid-acting treatments for severe depression and anxiety, but they are not the same. IV ketamine is a broader-acting compound delivered directly into the bloodstream and is used off-label for a wide range of conditions. Spravato® is a specific molecule of ketamine (esketamine), delivered as an FDA-approved nasal spray strictly for treatment-resistant depression and major depression with suicidal thoughts in a certified clinic. Your best choice depends on your specific diagnosis, medical history, insurance coverage, and a thorough consultation with a qualified provider.
TL;DR
- Different Molecules, Different Delivery: IV ketamine is a mix of two mirror-image molecules delivered intravenously, while Spravato® is just one of those molecules (esketamine) given as a nasal spray. Compare the two treatments side-by-side.
- FDA Approval and Insurance: Spravato® is FDA-approved for specific types of depression, which often makes it easier to get covered by insurance. IV ketamine is used "off-label" and is less frequently covered, though this is changing. See the full cost and insurance breakdown.
- The In-Clinic Experience Varies: An IV ketamine session involves a 40-60 minute infusion, while a Spravato® session involves self-administering a nasal spray and then being monitored for two hours. Learn what to expect from an IV session.
- Efficacy and Use Cases: Both treatments have shown encouraging results in research, but their approved uses differ. Spravato® is specifically for well-defined depression cases, whereas IV ketamine is used for a broader spectrum, including anxiety, PTSD, and chronic pain. Explore who makes a good candidate for each.
In This Article
- What is the Difference: Ketamine vs. Esketamine (Spravato)?
- How Do Ketamine Infusions Work for Anxiety and Depression?
- What to Expect During a Spravato (Esketamine) Treatment Session?
- Ketamine vs. Spravato: A Quick Comparison for Anxiety and Depression
- Which is More Effective: IV Ketamine or Spravato for Treatment-Resistant Conditions?
- What are the Costs: Esketamine (Spravato) vs. Ketamine Infusion Prices in 2026?
- Are There Significant Side Effects to Consider?
- Who is a Good Candidate for IV Ketamine vs. Spravato Therapy?
- The Role of Ketamine in the Future of Mental Health Treatment in 2026 and Beyond
- Frequently Asked Questions
What is the Difference: Ketamine vs. Esketamine (Spravato)?
The primary difference lies in their chemical makeup and how they are approved for use. Think of ketamine as having two parts that are mirror images of each other, like your left and right hands. Ketamine, used in IV infusions, contains both of these molecules (called R-ketamine and S-ketamine). Esketamine, the active ingredient in Spravato®, is only the S-ketamine molecule, which was isolated because it binds more tightly to certain receptors in the brain.
IV ketamine has been used safely as an anesthetic for decades and is now used "off-label" for mental health conditions. This means that while it's legal and widely accepted by doctors for this purpose, it hasn't gone through the formal, expensive FDA approval process specifically for depression.
On the other hand, Spravato® (esketamine) went through that process and gained FDA approval in 2019 specifically for:
- Treatment-resistant depression (TRD) in adults.
- Major Depressive Disorder (MDD) with acute suicidal ideation or behavior.
This FDA approval is a key reason why Spravato® is often covered by insurance, while IV ketamine coverage can be more hit-or-miss. In essence, Spravato® is a specific, branded version of a part of the ketamine molecule developed for a narrow, but critical, set of conditions.
How Do Ketamine Infusions Work for Anxiety and Depression?
Intravenous (IV) ketamine works differently from traditional antidepressants like SSRIs, which primarily focus on serotonin. Ketamine targets the brain's glutamate system, which is responsible for much of the brain's communication. It blocks a receptor called NMDA, leading to a surge of glutamate. This surge triggers a cascade of events that help the brain form new neural connections.
Synaptogenesis is the process of building new synapses, or connections, between brain cells. Chronic stress, depression, and anxiety can damage these connections, but ketamine helps rapidly rebuild them, almost like a fertilizer for your brain. This can lead to rapid improvements in mood and thought patterns.
During a treatment, you'll relax in a comfortable chair while the medicine is delivered slowly through an IV over about 40-60 minutes. Many people report a mild, dream-like, or dissociative state—a feeling of being disconnected from your body or reality. In our experience, patients often describe this as a calm, reflective, and sometimes profound experience. It's not "scary" for most, and you are monitored by a medical professional the entire time. You can learn more about what to expect during an IV ketamine treatment to feel more prepared.
This powerful reset is why ketamine infusion therapy can provide relief in hours or days, not weeks or months. The dosage is carefully calculated for you, often starting around 0.5 mg per kilogram of body weight, and adjusted based on your response.
Key takeaway: IV ketamine may help "rewire" the brain by promoting new neural connections through the glutamate system, offering relief through a mechanism that is fundamentally different from traditional antidepressants.
What to Expect During a Spravato (Esketamine) Treatment Session?
A Spravato® treatment session is highly structured due to FDA regulations. Unlike an IV, you'll self-administer the esketamine using a disposable nasal spray device. Each device delivers a specific dose, and you'll typically use two or three devices, five minutes apart, under the direct supervision of a healthcare provider at a certified ketamine clinic boise.
After administering the final spray, the session enters a mandatory observation period. You will be required to stay at the clinic for at least two hours to be monitored for side effects like:
- Drowsiness or dizziness
- Dissociation (unusual or "out-of-body" feelings)
- A temporary increase in blood pressure
Because of these potential side effects, you cannot drive, operate machinery, or make important decisions on the day of your treatment. You must arrange for transportation home.
Spravato® is also prescribed as part of a comprehensive treatment plan that includes an oral antidepressant. It's not a standalone therapy. Its use is managed through a strict safety protocol called the Spravato® REMS (Risk Evaluation and Mitigation Strategy), which ensures that it's only administered in a safe, medically supervised setting.

Ketamine vs. Spravato: A Quick Comparison for Anxiety and Depression
IV ketamine and Spravato® both offer hope for treatment-resistant conditions, but their practical differences are significant. Depending on your diagnosis, insurance, and lifestyle, one may be a much better fit than the other. For those exploring Boise ketamine therapy for anxiety, understanding these apects is a critical first step.
Here is a side-by-side comparison of the two treatments:
| Feature | IV Ketamine Therapy | Spravato® (Esketamine) Nasal Spray |
|---|---|---|
| Administration | Intravenous (IV) infusion | Self-administered nasal spray |
| Molecule | Racemic mixture (R- and S-ketamine) | S-ketamine only |
| Session Duration | ~40-60 minute infusion, plus recovery | ~5-10 minute administration, then 2-hour monitoring |
| Setting | Medical clinic | Certified Spravato® treatment center |
| FDA Approval | Used "off-label" for depression, anxiety, PTSD, pain | FDA-approved for TRD & MDD with suicidal ideation |
| Typical Use | Broader range: depression, anxiety, PTSD, OCD, chronic pain | Narrower range: specific depression diagnoses |
| Insurance Coverage | Less common, but growing; often out-of-pocket | More likely to be covered by insurance |
| Efficacy Data | Robust clinical evidence from decades of use | Strong clinical trial data for its specific indications |
Research suggests both treatments can help, with studies indicating that many appropriate patients experience meaningful relief from their symptoms. The goal is to find the right path for your unique brain chemistry and life circumstances.
Key takeaway: The choice between IV ketamine and Spravato® involves a trade-off. Spravato® offers the convenience of FDA approval and better insurance coverage, while IV ketamine provides more dosing flexibility and has been used for a wider variety of conditions.
Which is More Effective: IV Ketamine or Spravato for Treatment-Resistant Conditions?
This is the million-dollar question, and the answer is nuanced because direct, large-scale, head-to-head studies are still limited. Both IV ketamine and Spravato® are highly effective for treatment-resistant depression (TRD), which is the primary condition they are both used for.
IV ketamine has a longer track record in clinical settings for mental health, and many practitioners believe the full racemic mixture (both S- and R-ketamine molecules) may offer a more robust or well-rounded therapeutic effect for some patients. The precise control over dosing with an IV infusion also allows clinicians to tailor the treatment exactly to a patient's needs in real-time.
Spravato®'s effectiveness is proven through the rigorous clinical trials required for FDA approval. For its specific indications—TRD and depression with acute suicidality—it is a powerful, evidence-based tool. Some research, including a 2026 meta-analysis published in the Journal of Affective Disorders, suggests that while both are highly effective, IV ketamine may have a slight edge in the initial intensity of antidepressant effect for some patient populations, though Spravato shows excellent long-term sustainability with its structured protocol.
Ultimately, "more effective" depends on the person. If you're seeking one of the premier ketamine solutions for depression in the Boise area, the best approach is a personalized one. A doctor can help determine if the broad action of IV ketamine or the targeted, FDA-approved protocol of Spravato Boise is a better match for your brain and your journey.

What are the Costs: Esketamine (Spravato) vs. Ketamine Infusion Prices in 2026?
Cost and insurance are often the most significant factors for patients when choosing between these therapies. Because of its FDA approval, Spravato® is much more likely to be covered by commercial insurance plans and Medicare, making the out-of-pocket expense potentially lower for eligible patients.
IV ketamine infusion Boise therapy, being off-label, is frequently not covered by insurance. Patients typically pay for these treatments out-of-pocket. However, some insurance plans are beginning to offer partial reimbursement, and clinics can provide you with a superbill to submit to your provider.
Here’s a general breakdown of a typical ketamine infusion cost per session in 2026, without insurance:
- IV Ketamine Infusion: The cost per session generally ranges from $400 to $700. An initial series of six infusions over 2-3 weeks is common, followed by maintenance infusions.
- Spravato® (Esketamine): The cost of the medication itself plus the mandatory 2-hour monitoring session can range from $600 to $900 per session. The initial treatment schedule is usually twice a week for four weeks.
⚠️ Important Note: These are only estimates. Always confirm costs directly with the clinic and your insurance provider. Even with insurance coverage for Spravato®, you may still be responsible for deductibles, co-pays, or co-insurance, which can be substantial.
Finding ketamine clinics that accept insurance 2026 is becoming easier, but it still requires careful research. Don't be afraid to ask clinics directly about payment plans, financing options, or assistance programs they may offer.
Are There Significant Side Effects to Consider?
Both IV ketamine and Spravato® are considered safe when administered in a medically supervised setting, but they do have potential side effects to be aware of. Most side effects are short-lived and occur during or immediately after the treatment session.
Common side effects for both include:
- Dissociation: Feeling disconnected from yourself or your surroundings.
- Dizziness and Drowsiness: This is why you cannot drive after a session.
- Increased Blood Pressure and Heart Rate: Your vitals are monitored throughout the session to ensure they stay within a safe range. This is a very common and expected transient effect.
- Nausea: Anti-nausea medication can be given proactively if this is a concern.
With Spravato® nasal spray, some people also experience throat or nasal irritation.
Long-term side effects are rare at the low doses used for mental health treatment. Concerns like bladder issues (cystitis) or cognitive problems are primarily associated with high-dose, frequent, illicit use of ketamine, not with medically supervised therapeutic protocols. Based on our analysis of clinical data, adherence to the prescribed treatment schedule and professional monitoring makes the risk of long-term complications very low.
Who is a Good Candidate for IV Ketamine vs. Spravato Therapy?
Determining if you're a good candidate for ketamine therapy Boise starts with a comprehensive evaluation from a qualified medical provider. They will review your mental and physical health history to recommend the safest and most effective path forward.
You might be a good candidate for IV Ketamine if:
- You have treatment-resistant depression, severe anxiety, PTSD, or OCD that hasn't responded to other treatments.
- You also suffer from certain chronic pain conditions like CRPS or fibromyalgia, as IV
ketamine for chronic pain managementis a recognized application. For example, a patient with both severe depression and fibromyalgia might find IV ketamine particularly beneficial due to its dual action on mood and pain pathways. - Your insurance provider offers some out-of-network reimbursement for ketamine therapy, or you are prepared for the out-of-pocket expense.
- You prefer a shorter session duration (a ~45-minute infusion versus a 2-hour observation).
You might be a good candidate for Spravato® if:
- You have a confirmed diagnosis of treatment-resistant depression (TRD) or Major Depressive Disorder with suicidal thoughts. These are its on-label FDA indications.
- You have robust insurance coverage that includes Spravato®, making it the more affordable option. For instance, a teacher who has tried three different SSRIs without success and whose insurance plan lists Spravato® as a covered medication would be a perfect candidate.
- You are comfortable with a longer clinic visit (2+ hours) and the nasal spray administration.
- You have tried and failed multiple other antidepressants, meeting the specific criteria for TRD that many insurance companies require.
In some cases, such as for patients with severe, acute suicidal ideation, Spravato® might be favored due to its specific FDA indication for this exact situation. Your provider at a ketamine clinic Boise will guide you through this decision-making process with compassion and expertise.

The Role of Ketamine in the Future of Mental Health Treatment in 2026 and Beyond
Ketamine-based treatments have opened a new chapter in psychiatry. For decades, mental health treatment was largely limited to medications that could take weeks or months to work, if they worked at all. Ketamine's ability to produce rapid and profound antidepressant effects has fundamentally changed what's possible.
Looking ahead, the landscape continues to evolve. We are seeing more research into:
- Optimizing treatment protocols for even better, longer-lasting results.
- Exploring the benefits of ketamine-assisted psychotherapy, where therapy sessions are integrated with the treatment.
- Understanding which patients respond best to which form of the medicine, leading to truly personalized care.
Ketamine has also paved the way for research into other psychedelic-assisted therapies, with ongoing clinical trials for substances like psilocybin and MDMA. In 2026, ketamine is no longer a fringe therapy; it is a vital, evidence-based tool that represents a paradigm shift toward treatments that actively help the brain heal itself.
Ready to Explore Ketamine or Spravato Treatment? Contact Our Friendly Team for a Consultation!
Frequently Asked Questions
Can I receive both IV ketamine and Spravato?
A: It's generally not recommended to combine both treatments simultaneously. A patient and their doctor will typically choose one path based on their evaluation. If one treatment isn't effective, it's possible to switch to the other, but they are not used together as a standard protocol.
Is ketamine therapy for anxiety and depression covered by insurance in Idaho?
A: Spravato® is often covered by insurance in Idaho, provided you meet the strict diagnostic criteria. Coverage for IV ketamine is less common but is improving. Some patients have success getting reimbursement through out-of-network benefits. It's crucial to speak directly with your insurance company and your chosen clinic to understand your potential out-of-pocket costs.
How long does the anti-depressant effect of ketamine or esketamine last?
A: The duration of relief varies significantly from person to person. After an initial series of treatments (known as an induction phase), the positive effects can last anywhere from a few weeks to several months. Most patients then transition to a maintenance schedule with periodic "booster" infusions or sessions as needed to maintain their progress.
If you have more questions, we encourage you to review these comprehensive ketamine therapy FAQs or reach out to our team directly.
Key Takeaways
To help you remember the most important points, here is a quick summary of the key differences between IV ketamine and Spravato®:
- Different Forms, Different Delivery: IV ketamine is the full racemic molecule delivered via infusion, while Spravato® is only the esketamine molecule delivered as a nasal spray.
- FDA Approval & Insurance: Spravato® is FDA-approved for specific depression diagnoses, making it more likely to be covered by insurance. IV ketamine is used off-label for a wider range of conditions and is often an out-of-pocket expense.
- The Clinic Experience: IV ketamine involves a 40-60 minute infusion. Spravato® involves self-administering a nasal spray followed by a mandatory two-hour observation period at the clinic.
- Effectiveness is Personal: Both treatments are highly effective. The "best" choice depends on your specific diagnosis, health history, insurance coverage, and a thorough consultation with a qualified provider.
- Safety is Paramount: Both treatments are safe when administered in a certified medical setting. Side effects are typically mild and short-lived, resolving shortly after the session.
Finding Your Path to Relief
Choosing between IV ketamine and Spravato® doesn't have to be overwhelming. The most important step is finding a compassionate, knowledgeable clinical team who can help you weigh the pros and cons for your unique situation. Both treatments represent a major advancement in mental healthcare, offering real hope for those who have felt stuck. By understanding how they work, you are already on the path to making an empowered decision. The goal is to find the right treatment that fits your needs, and for many in Idaho, the journey to finding one of the best ketamine clinics in 2026 starts with a simple, honest conversation.